Epidemiology of Chlamydia trachomatis infections
- Jeanne Marrazzo, MD, MPH, FACP, FIDSA
Jeanne Marrazzo, MD, MPH, FACP, FIDSA
- Professor and Chief, Division of Infectious Diseases
- University of Alabama at Birmingham School of Medicine
Chlamydia trachomatis is a sexually transmitted gram-negative bacterium that causes infection worldwide. In the US, it is the most commonly reported bacterial infection and a common cause of urethritis in men and cervicitis in women . The largely asymptomatic reservoir of infections provides an ongoing source for efficient disease transmission and also allows for silent disease. C. trachomatis infection can result in scarring of the Fallopian tubes, ovaries, endometrial lining, and occasionally, the adjacent perineum, which increases the risk of future ectopic pregnancy and tubal infertility . These consequences are the main reason that C. trachomatis is estimated to be the most costly nonviral sexually transmitted infection . With this in mind, screening programs aimed at preventing pelvic inflammatory disease (PID) in women began in the late 1980s in the US, and were formally endorsed by the US Preventive Screening Task Force (USPSTF) and other major organization in the mid-1990s . Other countries also have national chlamydia screening programs .
The epidemiology of C. trachomatis infection in adolescents and adults is discussed in this topic. The screening, clinical manifestations, diagnosis, and treatment of chlamydial infections in adolescents and adults are discussed in detail elsewhere. (See "Screening for sexually transmitted infections", section on 'Chlamydia and gonorrhea' and "Clinical manifestations and diagnosis of Chlamydia trachomatis infections" and "Treatment of Chlamydia trachomatis infection".)
Lymphogranuloma venereum, endemic trachoma, and chlamydia infections in the newborn are discussed in detail elsewhere. (See "Lymphogranuloma venereum" and "Trachoma" and "Chlamydia trachomatis infections in the newborn".)
C. trachomatis is a small gram-negative bacterium that is an obligate intracellular parasite. It has a distinct life-cycle consisting of two major phases:
●The small elementary bodies attach and penetrate into cells, changing into the metabolically active form, called the reticulate body, within six to eight hours. These forms create large inclusions within cells.To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2015. Atlanta, GA: US Department of Health and Human Services; October 2016.
- Davies B, Turner KM, Frølund M, et al. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis 2016; 16:1057.
- Owusu-Edusei K Jr, Chesson HW, Gift TL, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis 2013; 40:197.
- Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis 2013; 40:97.
- http://www.chlamydiascreening.nhs.uk/ (Accessed on July 02, 2014).
- Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276:1737.
- Miller WC, Zenilman JM. Epidemiology of chlamydial infection, gonorrhea, and trichomoniasis in the United States--2005. Infect Dis Clin North Am 2005; 19:281.
- Torrone E, Papp J, Weinstock H, Centers for Disease Control and Prevention (CDC). Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep 2014; 63:834.
- US Department of Health and Human Services. Indian health surveillance report: Sexually transmitted diseases 2011. June 2014. http://www.cdc.gov/std/stats/IHS/IHS-Surv-Report-2011_062314.pdf (Accessed on June 30, 2014).
- World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infection, 2008. 2012.
- WHO. Baseline report on global sexually transmitted infection surveillance, 2012. http://www.who.int/reproductivehealth/publications/rtis/9789241505895/en/.
- Parish WL, Laumann EO, Cohen MS, et al. Population-based study of chlamydial infection in China: a hidden epidemic. JAMA 2003; 289:1265.
- Götz HM, van Bergen JE, Veldhuijzen IK, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:24.
- Unemo M, Clarke IN. The Swedish new variant of Chlamydia trachomatis. Curr Opin Infect Dis 2011; 24:62.
- Gratrix J, Singh AE, Bergman J, et al. Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin Infect Dis 2015; 60:398.
- Trebach JD, Chaulk CP, Page KR, et al. Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures. Sex Transm Dis 2015; 42:233.
- Danby CS, Cosentino LA, Rabe LK, et al. Patterns of Extragenital Chlamydia and Gonorrhea in Women and Men Who Have Sex With Men Reporting a History of Receptive Anal Intercourse. Sex Transm Dis 2016; 43:105.
- Dombrowski JC. Do women need screening for extragenital gonococcal and chlamydial infections? Sex Transm Dis 2015; 42:240.
- Mena L, Wang X, Mroczkowski TF, Martin DH. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis 2002; 35:1167.
- Kahn RH, Mosure DJ, Blank S, et al. Chlamydia trachomatis and Neisseria gonorrhoeae prevalence and coinfection in adolescents entering selected US juvenile detention centers, 1997-2002. Sex Transm Dis 2005; 32:255.
- Nsuami M, Cammarata CL, Brooks BN, et al. Chlamydia and gonorrhea co-occurrence in a high school population. Sex Transm Dis 2004; 31:424.
- Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229.
- Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012; 50:2601.
- Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147:89.
- Brunham RC. Immunity to Chlamydia trachomatis. J Infect Dis 2013; 207:1796.
- Brunham RC, Pourbohloul B, Mak S, et al. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005; 192:1836.
- Niccolai LM, Livingston KA, Laufer AS, Pettigrew MM. Behavioural sources of repeat Chlamydia trachomatis infections: importance of different sex partners. Sex Transm Infect 2011; 87:248.
- Dunne EF, Chapin JB, Rietmeijer CA, et al. Rate and predictors of repeat Chlamydia trachomatis infection among men. Sex Transm Dis 2008; 35:S40.
- Gaydos CA, Wright C, Wood BJ, et al. Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers. Sex Transm Dis 2008; 35:233.
- Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145:564.
- Chandra A, Mosher WD, Copen C, Sionean C. Sexual behavior, sexual attraction, and sexual identity in the United States: data from the 2006-2008 National Survey of Family Growth. National health statistics reports 2011; 1.
- Patton ME, Kidd S, Llata E, et al. Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012. Clin Infect Dis 2014; 58:1564.
- Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41:67.
- Koper NE, van der Sande MA, Gotz HM, et al. Lymphogranuloma venereum among men who have sex with men in the Netherlands: regional differences in testing rates lead to underestimation of the incidence, 2006-2012. Euro Surveill 2013; 18.
- Ward H, Alexander S, Carder C, et al. The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study. Sex Transm Infect 2009; 85:173.
- de Vrieze NH, van Rooijen M, Schim van der Loeff MF, de Vries HJ. Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, The Netherlands: trends over time, symptomatology and concurrent infections. Sex Transm Infect 2013; 89:548.
- Hughes G, Alexander S, Simms I, et al. Lymphogranuloma venereum diagnoses among men who have sex with men in the U.K.: interpreting a cross-sectional study using an epidemic phase-specific framework. Sex Transm Infect 2013; 89:542.
- Macdonald N, Sullivan AK, French P, et al. Risk factors for rectal lymphogranuloma venereum in gay men: results of a multicentre case-control study in the U.K. Sex Transm Infect 2014; 90:262.
- Gorgos LM, Marrazzo JM. Sexually transmitted infections among women who have sex with women. Clin Infect Dis 2011; 53 Suppl 3:S84.
- Singh D, Fine DN, Marrazzo JM. Chlamydia trachomatis infection among women reporting sexual activity with women screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005. Am J Public Health 2011; 101:1284.
- Gottlieb SL, Berman SM, Low N. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? J Infect Dis 2010; 201 Suppl 2:S156.
- Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines. MMWR 2010; 59.
- LeFevre ML, U.S. Preventive Services Task Force. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 161:902.
- Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis 2014; 58:e1.
- Hoover KW, Tao G, Nye MB, Body BA. Suboptimal adherence to repeat testing recommendations for men and women with positive Chlamydia tests in the United States, 2008-2010. Clin Infect Dis 2013; 56:51.
- Hoover KW, Butler M, Workowski K, et al. STD screening of HIV-infected MSM in HIV clinics. Sex Transm Dis 2010; 37:771.
- Hoover KW, Leichliter JS, Torrone EA, et al. Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010. MMWR Suppl 2014; 63:80.
- PREVALENCE AND INCIDENCE
- United States
- - Incidence
- - Prevalence
- Extragenital infections
- COINFECTION WITH OTHER PATHOGENS
- RISK OF INFECTION
- General risk factors
- Risk of repeat infection
- Risk in men who have sex with men
- Risk in women who have sex with women
- SELECTIVE SCREENING
- INFORMATION FOR PATIENTS